tirzepatide surmount 2 SURMOUNT-2: Demonstrates Body Weight-Lowering Effects in T2D Surmount-5 - Page 1 |

Originally developed to help adults with type 2 diabetes manage their blood sugar, it has become widely recognized for its weight loss benefits

Clinical trials measure outcomes around ~6872 weeks, showing the full effect of consistent treatment + lifestyle support

GLP-1 growth is propelled by doubled prescription volume, label expansion into cardiometabolic comorbidities, and oral agents that broaden adoption among injection-averse patients

Pokhrel, B., Yuet, W

It is often considered by individuals who want to support the integrity of the intestinal lining, maintain healthy digestion, or promote a balanced gut environment